No abstract available
MeSH terms
-
Ado-Trastuzumab Emtansine
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Brentuximab Vedotin
-
Drug Design*
-
Drug Industry / trends
-
Humans
-
Immunoconjugates / administration & dosage
-
Immunoconjugates / therapeutic use*
-
Maytansine / administration & dosage
-
Maytansine / analogs & derivatives
-
Maytansine / therapeutic use
-
Molecular Targeted Therapy
-
Technology, Pharmaceutical / methods
-
Trastuzumab
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunoconjugates
-
Maytansine
-
Brentuximab Vedotin
-
Trastuzumab
-
Ado-Trastuzumab Emtansine